Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer

Michael Bouvet, Lee M. Ellis, Masahiko Nishizaki, Toshiyoshi Fujiwara, Wenbiao Liu, Corazon D. Bucana, Bingliang Fang, J. Jack Lee, Jack A. Roth

Research output: Contribution to journalArticle

229 Citations (Scopus)

Abstract

Recent studies have indicated that angiogenesis may be regulated, in part, by p53 tumor suppressor gene function. We hypothesized that wild-type p53 replacement would down-regulate vascular endothelial growth factor (VEGF) expression and inhibit angiogenesis. KM12L4 and SW620, human colon cancer cell lines with p53 mutations, were transduced with a replication-defective adenoviral vector containing the wild-type p53 gene (Ad5/CMV/p53). Reverse transcription-PCR confirmed the presence of p53 in Ad5/CMV/p53-transduced cells. Transduction of colon cancer cells with wild-type p53 decreased VEGF RNA expression compared with that of controls. The decrease in VEGF expression in SW620 cells was dose dependent, with a 49% decrease observed at a multiplicity of infection of 50, and a 71% decrease observed at a multiplicity of infection of 100. Similar effects were seen in KM12L4 cells. VEGF supernatant protein levels were significantly reduced compared with those in nontransduced controls 48 h after the introduction of wild-type p53. Ad5/CMV/p53 inhibited tumor cell-induced angiogenesis in vivo. Restoration of wild-type p53 expression may decrease tumor growth by inhibiting the angiogenic response. These findings may explain, in part, the bystander effect seen with p53 tumor suppressor gene therapy.

Original languageEnglish
Pages (from-to)2288-2292
Number of pages5
JournalCancer Research
Volume58
Issue number11
Publication statusPublished - Jun 1 1998

Fingerprint

p53 Genes
Adenoviridae
Colonic Neoplasms
Vascular Endothelial Growth Factor A
Down-Regulation
Tumor Suppressor Genes
Bystander Effect
Infection
Genetic Therapy
Reverse Transcription
Neoplasms
RNA
Cell Line
Polymerase Chain Reaction
Mutation
Growth
Proteins

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. / Bouvet, Michael; Ellis, Lee M.; Nishizaki, Masahiko; Fujiwara, Toshiyoshi; Liu, Wenbiao; Bucana, Corazon D.; Fang, Bingliang; Lee, J. Jack; Roth, Jack A.

In: Cancer Research, Vol. 58, No. 11, 01.06.1998, p. 2288-2292.

Research output: Contribution to journalArticle

Bouvet, Michael ; Ellis, Lee M. ; Nishizaki, Masahiko ; Fujiwara, Toshiyoshi ; Liu, Wenbiao ; Bucana, Corazon D. ; Fang, Bingliang ; Lee, J. Jack ; Roth, Jack A. / Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. In: Cancer Research. 1998 ; Vol. 58, No. 11. pp. 2288-2292.
@article{373740bc082740c9b7dea562f2ac6838,
title = "Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer",
abstract = "Recent studies have indicated that angiogenesis may be regulated, in part, by p53 tumor suppressor gene function. We hypothesized that wild-type p53 replacement would down-regulate vascular endothelial growth factor (VEGF) expression and inhibit angiogenesis. KM12L4 and SW620, human colon cancer cell lines with p53 mutations, were transduced with a replication-defective adenoviral vector containing the wild-type p53 gene (Ad5/CMV/p53). Reverse transcription-PCR confirmed the presence of p53 in Ad5/CMV/p53-transduced cells. Transduction of colon cancer cells with wild-type p53 decreased VEGF RNA expression compared with that of controls. The decrease in VEGF expression in SW620 cells was dose dependent, with a 49{\%} decrease observed at a multiplicity of infection of 50, and a 71{\%} decrease observed at a multiplicity of infection of 100. Similar effects were seen in KM12L4 cells. VEGF supernatant protein levels were significantly reduced compared with those in nontransduced controls 48 h after the introduction of wild-type p53. Ad5/CMV/p53 inhibited tumor cell-induced angiogenesis in vivo. Restoration of wild-type p53 expression may decrease tumor growth by inhibiting the angiogenic response. These findings may explain, in part, the bystander effect seen with p53 tumor suppressor gene therapy.",
author = "Michael Bouvet and Ellis, {Lee M.} and Masahiko Nishizaki and Toshiyoshi Fujiwara and Wenbiao Liu and Bucana, {Corazon D.} and Bingliang Fang and Lee, {J. Jack} and Roth, {Jack A.}",
year = "1998",
month = "6",
day = "1",
language = "English",
volume = "58",
pages = "2288--2292",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "11",

}

TY - JOUR

T1 - Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer

AU - Bouvet, Michael

AU - Ellis, Lee M.

AU - Nishizaki, Masahiko

AU - Fujiwara, Toshiyoshi

AU - Liu, Wenbiao

AU - Bucana, Corazon D.

AU - Fang, Bingliang

AU - Lee, J. Jack

AU - Roth, Jack A.

PY - 1998/6/1

Y1 - 1998/6/1

N2 - Recent studies have indicated that angiogenesis may be regulated, in part, by p53 tumor suppressor gene function. We hypothesized that wild-type p53 replacement would down-regulate vascular endothelial growth factor (VEGF) expression and inhibit angiogenesis. KM12L4 and SW620, human colon cancer cell lines with p53 mutations, were transduced with a replication-defective adenoviral vector containing the wild-type p53 gene (Ad5/CMV/p53). Reverse transcription-PCR confirmed the presence of p53 in Ad5/CMV/p53-transduced cells. Transduction of colon cancer cells with wild-type p53 decreased VEGF RNA expression compared with that of controls. The decrease in VEGF expression in SW620 cells was dose dependent, with a 49% decrease observed at a multiplicity of infection of 50, and a 71% decrease observed at a multiplicity of infection of 100. Similar effects were seen in KM12L4 cells. VEGF supernatant protein levels were significantly reduced compared with those in nontransduced controls 48 h after the introduction of wild-type p53. Ad5/CMV/p53 inhibited tumor cell-induced angiogenesis in vivo. Restoration of wild-type p53 expression may decrease tumor growth by inhibiting the angiogenic response. These findings may explain, in part, the bystander effect seen with p53 tumor suppressor gene therapy.

AB - Recent studies have indicated that angiogenesis may be regulated, in part, by p53 tumor suppressor gene function. We hypothesized that wild-type p53 replacement would down-regulate vascular endothelial growth factor (VEGF) expression and inhibit angiogenesis. KM12L4 and SW620, human colon cancer cell lines with p53 mutations, were transduced with a replication-defective adenoviral vector containing the wild-type p53 gene (Ad5/CMV/p53). Reverse transcription-PCR confirmed the presence of p53 in Ad5/CMV/p53-transduced cells. Transduction of colon cancer cells with wild-type p53 decreased VEGF RNA expression compared with that of controls. The decrease in VEGF expression in SW620 cells was dose dependent, with a 49% decrease observed at a multiplicity of infection of 50, and a 71% decrease observed at a multiplicity of infection of 100. Similar effects were seen in KM12L4 cells. VEGF supernatant protein levels were significantly reduced compared with those in nontransduced controls 48 h after the introduction of wild-type p53. Ad5/CMV/p53 inhibited tumor cell-induced angiogenesis in vivo. Restoration of wild-type p53 expression may decrease tumor growth by inhibiting the angiogenic response. These findings may explain, in part, the bystander effect seen with p53 tumor suppressor gene therapy.

UR - http://www.scopus.com/inward/record.url?scp=0032101647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032101647&partnerID=8YFLogxK

M3 - Article

C2 - 9622060

AN - SCOPUS:0032101647

VL - 58

SP - 2288

EP - 2292

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 11

ER -